Beilei Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Beilei Xu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Wenbin Sun
School of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China; Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, 150076, PR China
3 shared publicationsDongqi Zhang
School of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China; Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, 150076, PR China
2 shared publications- Shusen Liu
School of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China; Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, 150076, PR China
2 shared publications Bo Yang
School of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China; Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, 150076, PR China
1 shared publicationDi Wu
School of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China; Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, 150076, PR China
1 shared publicationFeng Wei
National Institutes for Food and Drug Control, Beijing, 100050, China
1 shared publication
Latest Publications
- 23 October 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 374 (Pt 3) , 122569
Active components alignment of Gegen Qinlian Decoction for inflammatory bowel disease: exploring the possible role of the SphK1/S1P/NF-κB pathway
- 23 October 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 374 (Pt 3) , 122569
Active components alignment of Gegen Qinlian Decoction for inflammatory bowel disease: exploring the possible role of the SphK1/S1P/NF-κB pathway
- 19 December 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 359, 121073
Renshen Shouwu formula alleviates Alzheimer's disease pathology by modulating tryptophan metabolism and activating the SIRT1 signaling pathway
- 19 December 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 359, 121073
Renshen Shouwu formula alleviates Alzheimer's disease pathology by modulating tryptophan metabolism and activating the SIRT1 signaling pathway
- 4 October 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 2) , 118879
Protective effects and mechanisms of HuDiChangRong capsule on TNBS-induced ulcerative colitis in mice
- 4 October 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 2) , 118879
Protective effects and mechanisms of HuDiChangRong capsule on TNBS-induced ulcerative colitis in mice